Drug intelligence / Profile preview

Exoluma

Development stage
Unknown
Lead developer
Genèse Labs
Modality
Recombinant Proteins and Enzymes, Peptides, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intradermal
01

Overview

Exoluma is a professional-grade exosome-based aesthetic product developed for skin rejuvenation and hair restoration. The treatment system typically consists of a dual-vial kit: one vial containing lyophilized exosomes (approximately 6 billion particles) derived from human adipose-derived stem cells (ADSC), and a second vial containing an activating solution enriched with hyaluronic acid, growth factors, peptides, amino acids, and vitamins. As a regenerative biologic, Exoluma facilitates intercellular communication by delivering a cargo of signaling molecules, including proteins and miRNAs, directly to target cells. This process stimulates fibroblast proliferation, enhances the synthesis of collagen and elastin, and modulates inflammatory pathways to improve skin texture, tone, and elasticity. In hair applications, it is used to revitalize dormant hair follicles and promote hair growth. It is primarily administered topically in professional settings following procedures such as microneedling, mesotherapy, or laser therapy to ensure optimal absorption.

Brand names
Exoluma
Other names
Exoluma SkinExoluma Hair
02

Targets

PDGFR (PDGFR family)FGFR (FGFR family)VEGFR (VEGFR family)

Beyond the preview

Go deeper on Exoluma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exoluma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call